Steve

Early investor in the Psychedelic Sector. Proponent for Nuclear Energy/Psychedelic Medicine.

[Steve @Waracken]

Safe and abundant nuclear energy for everyone

[ₕₐₘₚₜₒₙ @hamptonism]

Anduril CEO, Palmer Lucky explains what he would do if he could wave a magic wand and change the world:

[Steve @Waracken]

@RJCcapital Not at this valuation

[Steve @Waracken]

I’m a $SPCX buyer sub $100

[Steve @Waracken]

@CudaMster @DeItaone @CoreyCicero We will see lol

[Steve @Waracken]

Lots of catalysts on the horizon. Really think $ILA:ASX is a sleeper at this price.

FDA Animal pathway allowed
Tropical Disease Priority Review Voucher eligible

Excited for the next 12 months

[islandpharmaceuticals @IslandPharma]

#WEBINAR: Join $ILA at 11am AEST (9am AWST) on Friday, 12 June as CEO Dr David Foster and Chairman Jason Carroll discuss the expanded USAMRIID CRADA, biodefence initiatives, and opportunities in Ebola and Sudan virus programs.

Register here: https://t.co/xZdJhUx9JV

[AtaiBeckley Inc @ataibeckley]

Delighted to share our latest article, The Challenge of Commercialising Psychedelic Medicines, in the Summer 2026 edition of @EBRmagazine.

Written by our Chief Medical Officer, Dr Kevin Craig, the article explores the path to clinical adoption for psychedelics in mental health - covering scalability, real-world delivery, and next-gen approaches bridging innovation with practical care.

Read the piece here (pages 53 - 55): https://t.co/wMbEaBCsRC

[Psychedelic Vantage @PsychedVantage]

New Frontiers in Psychedelic Research: Iboga Microdosing with Dr. @burtontabaac & Teresa Yung

https://t.co/lpWcBdt9Hy

[Psychedelic Vantage @PsychedVantage]

Changes in anxiety, quality of life, and functioning following psilocybin-assisted therapy in veterans with treatment-resistant depression

https://t.co/H4n7EX1RlH

[Steve @Waracken]

@Zetaboy69 @BellevueDoc Reintegration would more than likely be performed by their current therapist

[Steve @Waracken]

@Zetaboy69 @BellevueDoc I believe your definition of support matters here. Are you more so referring to reintegration?

It sounds like psychological support was there if needed, but they didn’t have specific support available as part of the treatment. Just as people needed assistance they’d provide it

[Steve @Waracken]

@Zetaboy69 @BellevueDoc I would say they are pursuing this no psychotherapy model to show that the drug works on its own. In the real world all of these patients are going to be seeing a therapist in some way during and throughout treatment. More than likely referred to this treatment by a therapist.

[Bloomberg @business]

Psychedelics have vast potential to help millions of patients with mental illness. But they aren’t without risks (via @opinion) https://t.co/f91Rt0lNBY

[Psychedelic Vantage @PsychedVantage]

As always, stellar reporting from @Psyched_Alpha. There is a lot of potential for psychedelics to treat addiction.

Along with treating addiction, many with substance use disorders have co-occurring mental health conditions and/or experience mood and anxiety symptoms as seen in post acute withdrawal.

There is a lot of potential in standalone depression and trauma for these compounds, but I happen to be most optimistic of their potential in both substance and behavioral addictions, when used with appropriate psychosocial support.

[Psychedelic Vantage @PsychedVantage]

Great to hear @C_Angermayer’s views on the potential of BPL-003 in addiction. I share his confidence.

$ATAI

[Polymarket @Polymarket]

NEW: The FDA is now likely to approve a psychedelic for medical use.

88% chance. https://t.co/oJ7dpIfAO9

[Steve @Waracken]

@Josh__Hardman 5MeO

[Steve @Waracken]

@itsmarkmoran I don’t think the compensation level is why they take back door donations and go corrupt. Many of them are simply greedy and no amount of upfront compensation would change that. PACs are more of an issue, imo.

[Steve @Waracken]

@obidientserf @BellevueDoc Why would it be worrisome for $atai?

[Katherine Cheung @Katherine_Chg]

Oregon’s psilocybin services (~$3000 at the higher end) are often described as quite expensive. But when making this claim, we should ask: expensive compared to what?

https://t.co/oalSerULFO

[TheChartGuys @ChartGuys]

Fun chat with @PsychedVantage talking charts and fundamentals for the sector's main leaders:
https://t.co/MzEC53sxAa

$CMPS $ATAI $DFTX $GHRS $HELP